Travere Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Travere Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About TVTX
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases.
CEOEric M. Dube
CEOEric M. Dube
Employees385
Employees385
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2008
Founded2008
Employees385
Employees385
TVTX Key Statistics
Market cap3.09B
Market cap3.09B
Price-Earnings ratio-31.88
Price-Earnings ratio-31.88
Dividend yield—
Dividend yield—
Average volume2.03M
Average volume2.03M
High today$38.00
High today$38.00
Low today$33.92
Low today$33.92
Open price$35.61
Open price$35.61
Volume2.88M
Volume2.88M
52 Week high$42.13
52 Week high$42.13
52 Week low$12.91
52 Week low$12.91
Stock Snapshot
With a market cap of 3.09B, Travere Therapeutics(TVTX) trades at $35.00. The stock has a price-to-earnings ratio of -31.88.
On 2026-01-11, Travere Therapeutics(TVTX) stock traded between a low of $33.92 and a high of $38.00. Shares are currently priced at $35.00, which is +3.2% above the low and -7.9% below the high.
Travere Therapeutics(TVTX) shares are trading with a volume of 2.88M, against a daily average of 2.03M.
In the last year, Travere Therapeutics(TVTX) shares hit a 52-week high of $42.13 and a 52-week low of $12.91.
In the last year, Travere Therapeutics(TVTX) shares hit a 52-week high of $42.13 and a 52-week low of $12.91.
Analyst ratings
87%
of 15 ratingsBuy
86.7%
Hold
13.3%
Sell
0%
People also own
Based on the portfolios of people who own TVTX. This list is generated using Robinhood data, and it’s not a recommendation.